No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position and insiders have been net selling.
Buys/Adds (2)
Qube Research
$55.6M
bought
Millennium
$36.0M
added
Sells/Trims (1)
FMR LLC
$89.6M
trimmed
Top-trader positions in R could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Oct 22, 2026
Period ending
Sep 30, 2026
Earnings per share
$4.17 expected
Estimates as of Oct 24, 2026
EPS expected
$3.97 to $4.38
Revenue expected
7 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Sep 30, 2026 | Oct 22, 2026 | $4.33 / $4.17Alpha Vantage | +3.84% beat | $3.43B No estimateSEC filing | Unavailable |
| Jun 30, 2026 | Jul 23, 2026 | $3.73 / $3.70Alpha Vantage | +0.81% in line | $3.35B No estimateSEC filing | Unavailable |
| Mar 31, 2026 | Apr 23, 2026 | $2.54 / $2.27Alpha Vantage | +11.89% beat | $3.13B No estimateSEC filing | Unavailable |
| Dec 31, 2025 | Feb 11, 2026 | $3.59 / $3.57Alpha Vantage | +0.56% in line | $3.19B No estimate | Unavailable |
| Sep 30, 2025 | Oct 23, 2025 | $3.57 / $3.54Alpha Vantage | +0.85% in line | $3.17B No estimateSEC filing | Unavailable |
| Jun 30, 2025 | Jul 24, 2025 | $3.32 / $3.10Alpha Vantage | +7.10% beat | $3.19B No estimateSEC filing | Unavailable |
| Mar 31, 2025 | Apr 23, 2025 | $2.46 / $2.39Alpha Vantage | +2.93% beat | $3.13B No estimateSEC filing | Unavailable |
| Dec 31, 2024 | Feb 12, 2025 | $3.45 / $3.37Alpha Vantage | +2.27% beat | $3.21B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $3.17B | $3.19B | $3.14B | $3.35B |
| Cost of what it sold | $2.51B | $2.55B | $2.53B | $2.82B |
| Gross profit | $668.0M | $637.0M | $606.0M | $523.0M |
| What it spent | ||||
| Sales and admin | $380.0M | $347.0M | $380.0M | $390.0M |
| Total operating expenses | $380.0M | $347.0M | $380.0M | $390.0M |
| What was left | ||||
| Operating profit | $288.0M | $290.0M | $226.0M | $133.0M |
| Interest on debt | $102.0M | $100.0M | $97.0M | $97.0M |
| Profit before tax | $190.0M | $177.0M | $118.0M | $185.0M |
| Tax | $51.0M | $44.0M | $25.0M | $52.0M |
| Net profit | $138.0M | $132.0M | $93.0M | $133.0M |
| EBITDA | $847.0M | $847.0M | $746.0M | $1.25B |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace